MSB 7.69% $1.19 mesoblast limited

MSB Trading 2020 - a new dawn, page-546

  1. 1,786 Posts.
    lightbulb Created with Sketch. 503
    I concur everything you have said ddwn,

    Dplane's summary of this mornings Oncologic Drugs Advisory Committee (ODAC) hearing was excellent and much appreciated.

    The Hook-up with SI discussing the recent event around 10.30am this morning really did not sink in and I think he like most of us were a bit exhausted with the process.

    There are many who have been so positive thru this journey and I personally wanted to thank ecoool2 as he was my tipping point for joining the believers.

    This pandemic has been a serious topic at home with my RN wife who works on the frontline with aged care patients - what MSB debated today was for its remestemcel-L product, a candidate treatment for paediatric steroid-resistance acute graft versus host disease (paediatric SR-aGvHD) and got the tick, this is fantastic news for kids but not the solution to Covid-19 as I think many SP buyers jumped on board based on rumour, it's not a vaccine and we may never find one as this bug is viral & mutates.

    My understanding of Mesoblast is their extraordinary vision of what Stemcell technology will bring to those who face death in ICU's wards on ventilators, wombat777 pointed out earlier around 36% of people that end up in the ICU on ventilators with Acute Respiratory Distress {ARDS} caused by COVID will die & if Mesoblast's allogeneic stemcell product is approved by the FDA soon it should significantly reduce that mortality rate.

    So we offer a treatment - not a cure

    As for their other developments, with the phase 3 readouts of Heart Failure and Chronic Lower Back Pain trials underway (hopefully by end Sep) our investment in Mesoblast is sound & solid moving forward no matter what the financial manipulators try to do.

    This is not financial advice either Mr Moderator.

    ST



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.